LH RSI Chart
Last 7 days
0.1%
Last 30 days
-4.6%
Last 90 days
-9.9%
Trailing 12 Months
5.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 12.3B | 0 | 0 | 0 |
2023 | 13.0B | 13.1B | 13.3B | 12.2B |
2022 | 9.6B | 8.7B | 7.5B | 10.6B |
2021 | 18.1B | 19.2B | 22.3B | 13.1B |
2020 | 10.9B | 10.2B | 9.5B | 16.8B |
2019 | 11.4B | 11.4B | 11.5B | 11.6B |
2018 | 10.7B | 11.1B | 11.3B | 11.3B |
2017 | 9.6B | 9.7B | 9.9B | 10.3B |
2016 | 16.5B | 16.7B | 16.8B | 16.8B |
2015 | 6.4B | 7.1B | 7.9B | 8.7B |
2014 | 10.4B | 10.4B | 10.5B | 10.6B |
2013 | 5.7B | 5.7B | 5.8B | 5.8B |
2012 | 5.6B | 5.6B | 5.6B | 5.7B |
2011 | 5.2B | 5.3B | 5.5B | 5.5B |
2010 | 4.7B | 4.8B | 4.9B | 5.0B |
2009 | 4.6B | 4.6B | 4.6B | 4.7B |
2008 | 0 | 4.2B | 4.4B | 4.5B |
2007 | 0 | 0 | 0 | 4.1B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index
Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.
Returns of $10,000 invested in:
Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022
Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 02, 2024 | anderson kerrii b | sold | -50,024 | 200 | -250 | - |
Apr 30, 2024 | eisenberg glenn a | sold (taxes) | -905,360 | 201 | -4,496 | chief financial officer, evp |
Apr 30, 2024 | anderson kerrii b | sold | -51,033 | 204 | -250 | - |
Apr 30, 2024 | eisenberg glenn a | acquired | - | - | 10,229 | chief financial officer, evp |
Apr 29, 2024 | wilkinson peter j | sold | -498,358 | 204 | -2,439 | svp, chief accounting officer |
Apr 15, 2024 | eisenberg glenn a | acquired | - | - | 10,229 | chief financial officer, evp |
Apr 15, 2024 | eisenberg glenn a | sold (taxes) | -914,127 | 203 | -4,496 | chief financial officer, evp |
Apr 01, 2024 | schroeder mark s | sold | -1,407,390 | 217 | -6,477 | evp, pres diagnostics & coo |
Apr 01, 2024 | bailey megan d. | acquired | - | - | 205 | evp, chief strategy officer |
Which funds bought or sold LH recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 06, 2024 | Carnegie Capital Asset Management, LLC | unchanged | - | -14,420 | 356,745 | 0.01% |
May 06, 2024 | Wealthspire Advisors, LLC | reduced | -1.72 | -45,395 | 774,441 | 0.01% |
May 06, 2024 | Cohen Capital Management, Inc. | added | 1.55 | -78,160 | 3,182,090 | 0.56% |
May 06, 2024 | Parallel Advisors, LLC | reduced | -1.59 | -20,717 | 366,025 | 0.01% |
May 06, 2024 | Empirical Finance, LLC | added | 3.22 | -5,755 | 721,573 | 0.04% |
May 06, 2024 | HighTower Advisors, LLC | reduced | -4.38 | -552,000 | 6,105,000 | 0.01% |
May 06, 2024 | Wealth Advisors of Tampa Bay, LLC | reduced | -0.15 | -74,430 | 1,774,120 | 0.84% |
May 06, 2024 | SG Americas Securities, LLC | added | 283 | 3,694,000 | 5,072,000 | 0.02% |
May 06, 2024 | Roundview Capital LLC | reduced | -0.35 | -60,453 | 1,371,930 | 0.11% |
May 06, 2024 | Savant Capital, LLC | added | 38.17 | 176,406 | 714,128 | 0.01% |
Unveiling Laboratory Corp of America Holdings's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Peers (Alternatives to Laboratory Corp of America Holdings)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 184.3B | 23.7B | 41.87 | 7.76 | ||||
A | 41.4B | 6.7B | 33.5 | 6.15 | ||||
IDXX | 40.0B | 3.7B | 46.15 | 10.74 | ||||
DGX | 15.2B | 9.3B | 17.98 | 1.64 | ||||
MEDP | 12.5B | 2.0B | 39.87 | 6.35 | ||||
CRL | 12.1B | 4.1B | 25.56 | 2.94 | ||||
NTRA | 11.7B | 1.1B | -27 | 10.84 | ||||
EXAS | 11.1B | 2.5B | -54.61 | 4.46 | ||||
MID-CAP | ||||||||
NEOG | 2.7B | 929.2M | 1.7K | 2.89 | ||||
GH | 2.3B | 563.9M | -4.78 | 4.06 | ||||
SMALL-CAP | ||||||||
CDNA | 542.6M | 280.3M | -2.85 | 1.94 | ||||
ACRS | 95.5M | 31.1M | -1.24 | 3.07 | ||||
APDN | 61.1M | 9.0M | -8.46 | 6.79 | ||||
AWH | 36.4M | 9.2M | -2.18 | 3.98 | ||||
BIOC | 183.8K | 25.9M | -0.01 | 0.01 |
Laboratory Corp of America Holdings News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 4.7% | 3,177 | 3,033 | 3,057 | 3,034 | 3,038 | 4,182 | 2,867 | 2,923 | 640 | 1,071 | 4,063 | 3,841 | 4,162 | 10,220 | 947 | 2,769 | 2,824 | 2,953 | 2,918 | 2,882 | 2,835 |
Cost Of Revenue | 3.0% | 2,279 | 2,212 | 2,206 | 2,192 | 2,188 | 1,829 | 1,981 | 1,981 | 2,667 | 328 | 2,677 | 2,576 | 2,563 | 2,585 | 2,337 | 2,008 | 2,096 | 2,133 | 2,111 | 2,057 | 2,002 |
Gross Profit | 9.2% | 897 | 821 | 851 | 842 | 850 | 723 | 886 | 943 | 1,233 | 743 | 1,386 | 1,265 | 1,599 | 1,905 | 1,559 | 761 | 728 | 821 | 817 | 825 | 790 |
S&GA Expenses | -4.6% | 508 | 533 | 526 | 506 | 457 | 434 | 453 | 432 | 464 | 282 | 520 | 459 | 430 | 518 | 420 | 396 | 396 | 414 | 402 | 415 | 394 |
Interest Expenses | -3.9% | 47.00 | 49.00 | 50.00 | 50.00 | 51.00 | 49.00 | 46.00 | 42.00 | 42.00 | 43.00 | 42.00 | 78.00 | 49.00 | 48.00 | 51.00 | 53.00 | 55.00 | 64.00 | 61.00 | 59.00 | 57.00 |
Income Taxes | 250.8% | 69.00 | 20.00 | 55.00 | 50.00 | 64.00 | -35.65 | 38.00 | 92.00 | 148 | 75.00 | 180 | 183 | 252 | 304 | 243 | 65.00 | 49.00 | 66.00 | 66.00 | 79.00 | 69.00 |
Net Income | 236.4% | 228 | -167 | 183 | 189 | 213 | 76.00 | 353 | 359 | 492 | 553 | 587 | 467 | 770 | 938 | 703 | 232 | -317 | 227 | -317 | 190 | 186 |
Net Income Margin | 2.4% | 0.04* | 0.03* | 0.06* | 0.07* | 0.09* | 0.12* | 0.23* | 0.23* | 0.22* | 0.18* | 0.12* | 0.15* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -139.7% | -163 | 412 | 171 | 264 | 27.00 | 555 | 291 | 442 | 239 | 586 | 650 | 390 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -1.2% | 16,531 | 16,725 | 16,886 | 17,719 | 20,200 | 20,155 | 19,826 | 20,403 | 20,728 | 20,385 | 20,867 | 20,417 | 20,417 | 20,072 | 18,740 | 17,849 | 17,298 | 18,046 | 17,848 | 17,744 | 16,971 |
Current Assets | -8.2% | 3,457 | 3,765 | 3,954 | 5,121 | 4,695 | 4,625 | 4,372 | 5,031 | 5,230 | 5,331 | 6,021 | 5,694 | 5,638 | 5,125 | 4,086 | 3,413 | 2,891 | 2,981 | 2,988 | 2,849 | 2,885 |
Cash Equivalents | -81.5% | 99.00 | 537 | 728 | 1,931 | 394 | 321 | 410 | 978 | 1,234 | 1,381 | 2,037 | 1,963 | 1,891 | 1,321 | 667 | 557 | 324 | 338 | 361 | 265 | 349 |
Inventory | 0.1% | 475 | 475 | 461 | 488 | 481 | 471 | 468 | 436 | 441 | 401 | 411 | 421 | 428 | 423 | 393 | 342 | 254 | 245 | 235 | 220 | 234 |
Net PPE | -0.5% | 2,898 | 2,912 | 2,821 | 2,762 | 2,944 | 2,794 | 2,885 | 2,870 | 2,808 | 2,815 | 2,692 | 2,702 | 2,697 | 2,730 | 2,609 | 2,628 | 2,610 | 2,637 | 2,463 | 2,544 | 2,458 |
Goodwill | 1.2% | 6,219 | 6,143 | 6,332 | 6,182 | 8,116 | 6,124 | 8,218 | 8,114 | 8,166 | 5,891 | 7,907 | 7,745 | 7,721 | 7,752 | 7,614 | 7,423 | 7,389 | 7,865 | 7,815 | 7,844 | 7,386 |
Liabilities | -3.2% | 8,556 | 8,835 | 8,994 | 8,914 | 9,839 | 10,040 | 9,715 | 9,982 | 9,987 | 10,091 | 10,321 | 10,151 | 10,375 | 10,614 | 10,481 | 10,477 | 10,260 | 10,459 | 10,597 | 10,580 | 9,840 |
Current Liabilities | 22.2% | 3,942 | 3,225 | 2,901 | 2,183 | 2,886 | 3,079 | 2,522 | 2,643 | 2,642 | 2,783 | 2,888 | 2,667 | 3,369 | 3,079 | 3,010 | 3,034 | 2,458 | 2,656 | 2,555 | 2,496 | 2,527 |
Long Term Debt | -24.8% | 3,048 | 4,055 | 4,428 | 5,042 | 5,052 | 5,039 | 5,334 | 5,360 | 5,383 | 5,417 | 5,417 | 5,423 | 4,921 | 5,419 | 5,417 | 5,417 | 5,790 | 5,790 | 6,101 | 6,135 | 5,496 |
LT Debt, Non Current | -24.8% | 3,048 | 4,055 | 4,428 | 5,042 | 5,052 | 5,039 | 5,334 | 5,360 | 5,383 | 5,417 | 5,417 | 5,423 | 4,921 | 5,419 | 5,417 | 5,417 | 5,790 | 5,790 | 6,101 | 6,135 | 5,496 |
Shareholder's Equity | 1.1% | 7,960 | 7,875 | 7,873 | 8,785 | 10,342 | 10,097 | 10,092 | 10,401 | 10,721 | 10,273 | 10,601 | 10,322 | 10,098 | 9,437 | 8,239 | 7,353 | 7,020 | 7,644 | 7,020 | 7,144 | 7,111 |
Retained Earnings | 2.1% | 8,055 | 7,888 | 8,070 | 8,836 | 10,730 | 10,582 | 10,845 | 10,898 | 10,948 | 10,457 | 10,787 | 10,417 | 10,172 | 9,479 | 8,464 | 7,761 | - | 7,981 | 7,677 | 7,456 | 7,265 |
Additional Paid-In Capital | 113.5% | 82.00 | 38.00 | 5.00 | 94.00 | 48.00 | - | - | - | 29.00 | - | - | - | 67.00 | 110 | 81.00 | 32.00 | - | 27.00 | 48.00 | 91.00 | 1,401 |
Shares Outstanding | 0.5% | 84.00 | 84.00 | 85.00 | 89.00 | 103 | 88.00 | 104 | 106 | 112 | 108 | 112 | 113 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 17,300 | - | - | - | 20,200 | - | - | - | 24,800 | - | - | - | 15,200 | - | - | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -105.1% | -29.80 | 580 | 276 | 351 | 121 | 654 | 374 | 573 | 356 | 698 | 767 | 487 | 1,158 | 775 | 786 | 371 | 204 | 570 | 456 | 254 | 166 |
Share Based Compensation | 17.0% | 32.00 | 27.00 | 34.00 | 34.00 | 33.00 | 24.00 | 30.00 | 26.00 | 38.00 | 21.00 | 59.00 | 24.00 | 29.00 | 27.00 | 27.00 | 40.00 | 18.00 | 24.00 | 32.00 | 27.00 | 26.00 |
Cashflow From Investing | -18.9% | -393 | -330 | -487 | -253 | -99.70 | -273 | -563 | -242 | -573 | -254 | -407 | -90.40 | -132 | -128 | -285 | -123 | -106 | -152 | -239 | -750 | -140 |
Cashflow From Financing | 97.4% | -11.70 | -446 | -1,097 | 1,545 | -60.60 | -372 | -452 | -479 | -17.70 | -1,008 | -281 | -325 | -450 | -1.00 | -396 | -16.90 | -102 | -449 | -115 | 415 | -103 |
Dividend Payments | - | 62.00 | - | 64.00 | 65.00 | 64.00 | - | 65.00 | 67.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buy Backs | 100.0% | - | -9.00 | 1,009 | - | - | 300 | 400 | 400 | - | 1,000 | 300 | 300 | 69.00 | -34.25 | 69.00 | - | 100 | 275 | 100 | 200 | 100 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Net restructuring and other special charges | $ 5.0 | $ 7.5 |
Operating Income (Loss) | 321.3 | 329.8 |
Interest Expense | 46.9 | 50.7 |
Equity method income, net | 0.1 | (2.1) |
Investment income | 2.9 | 2.2 |
Other, net | 20.0 | (6.9) |
Earnings before income taxes | 297.4 | 272.3 |
Provision for income taxes | 69.1 | 63.9 |
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | 228.3 | 208.4 |
Net earnings | 228.3 | 213.3 |
Net Income (Loss) Attributable to Noncontrolling Interest | 0.3 | 0.4 |
Net Income (Loss) Attributable to Parent | $ 228.0 | $ 212.9 |
Income (Loss) from Continuing Operations, Per Basic Share | $ 2.71 | $ 2.35 |
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share | 0 | 0.06 |
Basic earnings per common share (in dollars per share) | 2.71 | 2.41 |
Diluted earnings per common share (in dollars per share) | $ 2.69 | $ 2.39 |
Revenues | $ 3,176.6 | $ 3,037.8 |
Cost of Revenue | 2,279.3 | 2,187.7 |
Gross Profit | 897.3 | 850.1 |
Selling, general and administrative expenses | 508.4 | 457.2 |
Amortization of intangibles and other assets | 60.1 | 53.4 |
Asset Impairment Charges | 2.5 | 2.2 |
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $ 0.0 | $ 4.9 |
Income (Loss) from Continuing Operations, Per Diluted Share | $ 2.69 | $ 2.34 |
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share | $ 0 | $ 0.05 |
Revenues | $ 3,176.6 | $ 3,037.8 |
Cost of Revenue | 2,279.3 | 2,187.7 |
Gross Profit | 897.3 | 850.1 |
Selling, general and administrative expenses | 508.4 | 457.2 |
Amortization of intangibles and other assets | 60.1 | 53.4 |
Asset Impairment Charges | 2.5 | 2.2 |
Net restructuring and other special charges | 5.0 | 7.5 |
Operating Income (Loss) | 321.3 | 329.8 |
Earnings before income taxes | 297.4 | 272.3 |
Provision for income taxes | 69.1 | 63.9 |
Net earnings | 228.3 | 213.3 |
Less: Net earnings attributable to the noncontrolling interest | (0.3) | (0.4) |
Net earnings attributable to Laboratory Corporation of America Holdings | $ 228.0 | $ 212.9 |
Basic earnings per common share (in dollars per share) | $ 2.71 | $ 2.41 |
Diluted earnings per common share (in dollars per share) | $ 2.69 | $ 2.39 |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Dec. 31, 2023 | |
Current assets: | ||
Accounts Receivable, after Allowance for Credit Loss, Current | $ 2,083,700,000 | $ 1,913,300,000 |
Unbilled Contracts Receivable | 120,400,000 | 185,400,000 |
Supplies inventories | 475,000,000.0 | 474,600,000 |
Prepaid expenses and other | 678,100,000 | 655,300,000 |
Total current assets | 3,456,500,000 | 3,765,400,000 |
Property, plant and equipment, net | 2,897,800,000 | 2,911,800,000 |
Goodwill, net | 6,218,900,000 | 6,142,500,000 |
Intangible Assets, Net (Excluding Goodwill) | 3,394,100,000 | 3,342,000,000 |
Joint venture partnerships and equity method investments | 17,700,000 | 26,900,000 |
Other assets, net | 546,000,000.0 | 536,500,000 |
Total assets | 16,531,000,000 | 16,725,100,000 |
Liabilities, Current [Abstract] | ||
Accounts Payable, Current | 695,500,000 | 827,500,000 |
Accrued Liabilities, Current | 649,300,000 | 804,000,000.0 |
Deferred Revenue, Current | 377,500,000 | 421,700,000 |
Operating Lease, Liability, Current | 171,300,000 | 165,800,000 |
Finance Lease, Liability, Current | 6,400,000 | 6,400,000 |
Current debt excluding finance lease liability | 2,041,500,000 | 999,800,000 |
Long-term debt, less current portion | 3,941,500,000 | 3,225,200,000 |
Long-term Debt, Excluding Current Maturities | 3,047,600,000 | 4,054,700,000 |
Commitments and contingent liabilities | 468,200,000 | 409,300,000 |
Operating Lease, Liability, Noncurrent | 624,600,000 | 648,900,000 |
Finance Lease, Liability, Noncurrent | 77,100,000 | 78,600,000 |
Deferred income taxes and other tax liabilities | 397,200,000 | 417,900,000 |
Noncontrolling interest | 8,556,200,000 | 8,834,600,000 |
Shareholders' equity: | ||
Common stock, 92.8 and 93.5 shares outstanding at March 31, 2013 and December 31, 2012, respectively | 15,200,000 | 15,500,000 |
Additional paid-in capital | 82,000,000.0 | 38,400,000 |
Retained earnings | 7,700,000 | 7,700,000 |
Accumulated other comprehensive income | (8,055,300,000) | (7,888,200,000) |
Total liabilities and shareholders' equity | (185,400,000) | (59,300,000) |
Stockholders' Equity Attributable to Parent | 7,959,600,000 | 7,875,000,000 |
Liabilities and Equity | 16,531,000,000 | 16,725,100,000 |
Net earnings | 228,300,000 | |
Cash and cash equivalents | $ 99,300,000 | $ 536,800,000 |